Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 24:2019:8908960.
doi: 10.1155/2019/8908960. eCollection 2019.

Hydrogen Sulfide Attenuates High Glucose-Induced Human Retinal Pigment Epithelial Cell Inflammation by Inhibiting ROS Formation and NLRP3 Inflammasome Activation

Affiliations

Hydrogen Sulfide Attenuates High Glucose-Induced Human Retinal Pigment Epithelial Cell Inflammation by Inhibiting ROS Formation and NLRP3 Inflammasome Activation

Peng Wang et al. Mediators Inflamm. .

Abstract

Hydrogen sulfide (H2S) has been shown to protect against oxidative stress injury and inflammation in various high glucose-induced insult models. However, it remains unknown whether H2S protects human retinal pigment epithelial cells (RPE cells) from high glucose-induced damage. In the current study, cell viability, proinflammatory cytokines, ROS, and inflammasome markers were compared in a low glucose- and high glucose-induced cell culture system. The antioxidant N-acetylcysteine (NAC), NLRP3 siRNA, and NaHS were used to test RPE cell responses. The results demonstrate that compared with the low-glucose culture, high glucose triggered higher cell death and increased IL-18 and IL-1β mRNA expression and protein production. Furthermore, high glucose increased the mRNA expression levels of NLRP3, ACS, and caspase-1. Notably, NAC, a ROS scavenger, could attenuate high glucose-induced ROS formation and IL-18 and IL-1β mRNA and protein expression and block inflammasome activation. Silencing the NLRP3 gene expression also abolished IL-18 and IL-1β mRNA and protein expression. Intrudingly, H2S could ameliorate high glucose-induced ROS formation, IL-18 and IL-1β expression, and inflammasome activation. Taken together, the findings of the present study have demonstrated that H2S protects cultured RPE cells from high glucose-induced damage through inhibiting ROS formation and NLRP3 inflammasome activation. It might suggest that H2S represents a potential therapeutic target for the treatment of diabetic retinopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The high-glucose condition decreased cell viability and induced proinflammatory cytokine IL-18 and IL-1β production in ARPE-19 cells. ARPE-19 cells were treated with high or low glucose for 48 hours. (a) Cell viability determined by the CCK-8 assay in the low-glucose group, high-glucose group, high-glucose+H2S group, and high-glucose+NAC group. (b) Protein levels of IL-18 detected by ELISA. (c) Protein levels of IL-1β detected by ELISA. (d) The mRNA expression levels of IL-18 determined by RT-PCR. (e) IL-1β mRNA levels measured by RT-PCR. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the low-glucose and high-glucose groups (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 2
Figure 2
The high-glucose condition increased intracellular ROS formation in ARPE-19 cells. ARPE-19 cells were treated with high or low glucose for 48 hours. ROS production was measured by FCM. (a) FACS results of low-glucose culture condition. (b) FAC results of high-glucose culture condition. (c) A bar graph of average results obtained from three individual experiments. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the low-glucose and high-glucose groups (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 3
Figure 3
The high glucose-induced activation of the inflammasome in ARPE-19 cells. The mRNA expression of NLRP3, ASC, and caspase-1 in ARPE-19 cells after low-glucose and high-glucose culture for 48 hours was determined by RT-PCR. (a) NLRP3 mRNA levels were relative to GAPDH. (b) ASC mRNA levels were relative to GAPDH. (c) Caspase-1 mRNA levels were relative to GAPDH. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the low-glucose and high-glucose groups (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 4
Figure 4
N-Acetylcysteine (NAC) attenuated intracellular ROS formation and inflammatory response. The inhibition of ROS by NAC decreased the gene expression of NLRP3, ASC, caspase-1, IL-18, and IL-1β and the protein expression of IL-18 and IL-1β in ARPE-19 cells. ARPE-19 cells were cultured under low or high glucose with or without 2.5 mM of NAC for 48 hours. The mRNA and protein expression levels of proinflammatory cytokines IL-18 and IL-1β and inflammasome activation markers NLRP3, ACS, and caspase-1 were determined, accordingly. (a) IL-18 mRNA; (b) IL-1β mRNA; (c) intracellular IL-18 protein levels; (d) intracellular IL-1β protein levels; (e) NLRP3 mRNA; (f) ASC mRNA; (g) caspase-1 mRNA. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the high-glucose and high-glucose+NAC groups (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 5
Figure 5
The knockdown of NLRP3 gene expression ameliorated high glucose-induced proinflammatory cytokine production and inflammasome activation. The gene expression levels of IL-18 and IL-1β and inflammasome markers NLRP3, ASC, and caspase 1 were measured in ARPE-19 cells with either NLRP3-siRNA or scrabbling siRNA transfection in low- and high-glucose culture for 48 hours. (a) NLRP3 mRNA; (b) ASC mRNA; (c) caspase-1 mRNA; (d) IL-18 mRNA; (e) IL-1β mRNA; (f) intracellular IL-18 protein levels; (g) intracellular IL-1β protein levels. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the high-glucose and high-glucose+NLRP3 siRNA groups. There was no statistical significance between the glucose group and the NLRP3 siRNA group (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 6
Figure 6
H2S decreased high glucose-induced ROS production and inflammatory response in RPE cells. Intracellular ROS formation and inflammasome marker NLRP3, ASC, and caspase-1 expression were determined in ARPE-19 cells after 48 hours of culture under low and high glucose, with or without 200 μM of NaHS pretreatment. (a) The ROS production indicated by FACs in high-glucose culture; (b) the ROS production indicated by FACs in high-glucose+NaHS culture; (c) a bar graph of average results from the three individual experiments; (d) NLRP3 mRNA; (e) ASC mRNA; (f) caspase-1 mRNA. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the high-glucose and high-glucose+H2S groups (low glucose: 5.5 mM, high glucose: 25 mM).
Figure 7
Figure 7
H2S decreased high glucose-induced proinflammatory cytokine IL-18 and IL-1β production in RPE cells. ARPE-19 cells were cultured in high glucose with or without 200 μM of NaHS pretreatment. The mRNA and intracellular protein expression levels were measured, accordingly. (a) IL-18 mRNA; (b) IL-1β mRNA; (c) intracellular IL-18 protein levels; (d) intracellular IL-1β protein levels. Data were presented as the mean ± standard error (SE) of three independent experiments. P < 0.05 and ∗∗P < 0.01, compared between the low-glucose and high-glucose groups (low glucose: 5.5 mM, high glucose: 25 mM).

References

    1. Cai J., Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16(3):242–260. doi: 10.1038/sj.eye.6700133. - DOI - PubMed
    1. Abu El-Asrar A. M., Midena E., Al-Shabrawey M., Mohammad G. New developments in the pathophysiology and management of diabetic retinopathy. Journal Diabetes Research. 2013;2013, article 424258:2. doi: 10.1155/2013/424258. - DOI - PMC - PubMed
    1. Cunha-Vaz J., Ribeiro L., Lobo C. Phenotypes and biomarkers of diabetic retinopathy. Progress in Retinal and Eye Research. 2014;41:90–111. doi: 10.1016/j.preteyeres.2014.03.003. - DOI - PubMed
    1. Tarr J. M., Kaul K., Chopra M., Kohner E. M., Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmology. 2013;2013:13. doi: 10.1155/2013/343560.343560 - DOI - PMC - PubMed
    1. Wu Y., Tang L., Chen B. Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Oxidative Medicine and Cellular Longevity. 2014;2014:12. doi: 10.1155/2014/752387.752387 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources